insights_auto
Why is KYMR up 2,29%?
Dive Deeperchevron_right
KYMR:NASDAQ
Kymera Therapeutics Inc
US$109,85
arrow_upward
+2,29%(+2,46) 1D
US$109,85
0,00% (0,00)
bedtimeAfter hours
Closed: 5 ຕ.ລ., 16 ໂມງ 0 ນາທີ 01 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for KYMR...
Open
US$108,38
High
US$109,92
Low
US$103,33
Mkt. cap
9,13 ຕື້
Avg. vol.
730,96 ພັນ
Volume
0,00
52-wk high
US$130,05
52-wk low
US$55,26
EPS
US$-3,24
Beta
1,98
Shares outstanding
83,15 ລ້ານ
No. of employees
273
Open
US$108,38
High
US$109,92
Low
US$103,33
Mkt. cap
9,13 ຕື້
Avg. vol.
730,96 ພັນ
Volume
0,00
52-wk high
US$130,05
52-wk low
US$55,26
EPS
US$-3,24
Beta
1,98
Shares outstanding
83,15 ລ້ານ
No. of employees
273
News stories
From web sources and news partners
GuruFocus
·
9 ຊົ່ວໂມງກ່ອນ
KYMR Maintained by Citigroup -- Price Target Raised to $150
Investing.com
·
19 ຊົ່ວໂມງກ່ອນ
Citi raises Kymera Therapeutics stock price target on drug potential
About Kymera Therapeutics Inc
CEO-
Employees273
Founded2015
HeadquartersWatertown, ມາຊາຊູເຊັດ, ສະຫະລັດ
SectorBiotechnology
Websitekymeratx.com